MarketCapTrends
EBS
Emergent BioSolutions Inc. (EBS)
NYSE · Healthcare

Emergent BioSolutions Inc. Cash on Hand 2009–2025

Emergent BioSolutions Inc. annual/quarterly cash on hand history from 2010 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.

  • Emergent BioSolutions Inc. cash on hand for the quarter ending December 31, 2025 were 205.4M, a 106.43% increase year-over-year.
  • Emergent BioSolutions Inc. cash on hand for 2025 were 205.4M, a 106.43% increase from 2024.
  • Emergent BioSolutions Inc. cash on hand for 2024 were 99.5M, a 10.92% decrease from 2023.
  • Emergent BioSolutions Inc. cash on hand for 2023 were 111.7M, a 82.62% decrease from 2022.
  • Emergent BioSolutions Inc. cash on hand for 2022 were 642.6M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Emergent BioSolutions Inc. Annual Cash on Hand (Millions of US $)
2025$205
2024$100
2023$112
2022$643
2021$576
2020$621
2019$168
2018$112
2017$178
2016$272
2015$313
2014$280
2013$179
2012$142
2011$144
Emergent BioSolutions Inc. Quarterly Cash on Hand (Millions of US $)
2025-12-31$205
2024-12-31$100
2023-12-31$112
2022-12-31$643
2021-12-31$576
2020-12-31$621
2019-12-31$168
2018-12-31$112
2017-12-31$178
2016-12-31$272
2015-12-31$313
2014-12-31$280
2013-12-31$179
2012-12-31$142
2011-12-31$144
2010-12-31$169

Emergent BioSolutions Inc. Cash on Hand — FAQ

Emergent BioSolutions Inc. (EBS) cash on hand over the last 17 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see EBS's cash on hand history?

The chart and table above show Emergent BioSolutions Inc.'s cash on hand by year and by quarter, including the growth rate.